Trace Biosciences Inc.
One private offering reported to the SEC on Form D since 2016, $8.3M sold in all. Biotech, Oregon.
- Form D offerings: 1
- Reported sold: $8.3M
- Newest: Aug 12, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Filed | Round | Sold | Offering | Filed as | Last amended | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | โ | $8.3M | $16.2M | Trace Biosciences Inc.Biotech ยท Oregon | Not amended | 0002147501-26-000002 |
- Business address
- Beaverton, Or
- Incorporated in
- Delaware
- All SEC filings
- CIK 2147501 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR